Total Payments
$1,779
2024 Payments
$360.30
Companies
27
Transactions
102
Medicare Patients
1,731
Medicare Billing
$138,958
Payment Breakdown by Category
Food & Beverage$1,779 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,779 | 102 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $343.88 | 20 | $0 (2024) |
| Allergan, Inc. | $274.03 | 15 | $0 (2020) |
| Lilly USA, LLC | $186.90 | 12 | $0 (2024) |
| Novo Nordisk Inc | $148.66 | 8 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $98.33 | 6 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $91.63 | 5 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $73.61 | 4 | $0 (2018) |
| PFIZER INC. | $62.86 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $52.95 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $51.35 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $360.30 | 19 | ABBVIE INC. ($104.35) |
| 2023 | $234.55 | 13 | ABBVIE INC. ($82.43) |
| 2022 | $356.39 | 21 | SANOFI-AVENTIS U.S. LLC ($85.56) |
| 2021 | $223.69 | 14 | AbbVie Inc. ($78.39) |
| 2020 | $93.33 | 6 | Allergan, Inc. ($60.48) |
| 2019 | $54.28 | 4 | Shionogi Inc ($32.36) |
| 2018 | $124.29 | 8 | AstraZeneca Pharmaceuticals LP ($73.61) |
| 2017 | $331.81 | 17 | Allergan Inc. ($190.85) |
All Payment Transactions
102 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Bone Health | ||||||
| 07/09/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: VACCINES | ||||||
| 06/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Gastroenterology | ||||||
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Bone Health | ||||||
| 03/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.95 | General |
| 02/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.97 | General |
| 02/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX, BOOSTRIX | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: RESPIRATORY | ||||||
| 02/02/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: VACCINES | ||||||
| 01/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Diabetes | ||||||
| 11/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.36 | General |
| 08/31/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: VACCINES | ||||||
| 08/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: PSYCHIATRY | ||||||
| 08/11/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 663 | 1,035 | $130,271 | $51,514 |
| 2022 | 6 | 469 | 752 | $94,315 | $39,336 |
| 2021 | 4 | 285 | 438 | $62,270 | $25,537 |
| 2020 | 6 | 314 | 499 | $59,590 | $22,572 |
Total Patients
1,731
Total Services
2,724
Medicare Billing
$138,958
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 144 | 378 | $69,600 | $25,962 | 37.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 87 | 87 | $15,882 | $10,202 | 64.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 148 | $17,530 | $6,554 | 37.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 42 | 42 | $8,314 | $2,906 | 35.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 30 | 30 | $5,520 | $2,158 | 39.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 34 | $1,666 | $953.70 | 57.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $4,760 | $792.31 | 16.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 65 | 65 | $1,625 | $550.55 | 33.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 65 | 65 | $1,625 | $550.55 | 33.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 53 | 62 | $1,488 | $520.80 | 35.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 31 | $1,891 | $300.75 | 15.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 74 | $370.00 | $62.54 | 16.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 267 | $46,725 | $15,923 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 132 | 261 | $28,700 | $11,532 | 40.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 75 | 75 | $11,250 | $9,168 | 81.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 27 | 27 | $4,590 | $1,635 | 35.6% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 75 | 75 | $1,875 | $663.06 | 35.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 47 | 47 | $1,175 | $415.07 | 35.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 92 | 189 | $31,125 | $12,922 | 41.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 82 | 128 | $14,080 | $5,768 | 41.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 35 | 38 | $6,625 | $2,924 | 44.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 39 | $4,290 | $2,120 | 49.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 25 | 25 | $4,250 | $1,241 | 29.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 16 | 19 | $1,900 | $561.28 | 29.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 78 | 169 | $25,350 | $9,177 | 36.2% |
About Dr. Robert Partrige, MD
Dr. Robert Partrige, MD is a Family Medicine healthcare provider based in Wiggins, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265540603.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Partrige, MD has received a total of $1,779 in payments from pharmaceutical and medical device companies, with $360.30 received in 2024. These payments were reported across 102 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($1,779).
As a Medicare-enrolled provider, Partrige has provided services to 1,731 Medicare beneficiaries, totaling 2,724 services with total Medicare billing of $138,958. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Wiggins, MS
- Active Since 08/27/2006
- Last Updated 01/16/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1265540603
Products in Payments
- VRAYLAR (Drug) $233.25
- LINZESS (Drug) $134.17
- UBRELVY (Drug) $128.65
- TRINTELLIX (Drug) $91.63
- TRULICITY (Drug) $89.73
- SOLIQUA 100/33 (Biological) $78.25
- JARDIANCE (Drug) $76.43
- MOVANTIK (Drug) $73.61
- QULIPTA (Drug) $72.33
- PREVNAR 20 (Biological) $49.92
- Ozempic (Drug) $38.92
- BYSTOLIC (Drug) $36.61
- NURTEC ODT (Drug) $36.29
- Rybelsus (Drug) $36.04
- JANUVIA (Drug) $35.52
- EVENITY (Biological) $32.42
- Symproic (Drug) $32.36
- COLLAGENASE SANTYL (Drug) $30.22
- OFEV (Drug) $29.28
- XARELTO (Drug) $28.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Wiggins
Donald Doran, D.o, D.O
Family Medicine — Payments: $13,162
Family Medicine $13,162
Howard Westbrook, Md, MD
Family Medicine — Payments: $2,960
Family Medicine $2,960
Calvin Washington, M.d, M.D
Family Medicine — Payments: $1,728
Family Medicine $1,728
Dr. Jeffrey Potter, Md, MD
Family Medicine — Payments: $1,509
Family Medicine $1,509
Amber Norris, Do, DO
Family Medicine — Payments: $1,292
Family Medicine $1,292
Tiffany Worthington, Do, DO
Family Medicine — Payments: $673.73
Family Medicine $673.73